XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 625 shares, a growth of 2,876.2% from the March 15th total of 21 shares. Based on an average trading volume of 891 shares, the days-to-cover ratio is presently 0.7 days.
XOMA Trading Down 2.9%
NASDAQ XOMAP opened at $26.47 on Friday. The stock has a 50 day moving average price of $26.06 and a 200-day moving average price of $26.37. XOMA has a one year low of $24.96 and a one year high of $30.00.
XOMA Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Thursday, April 2nd will be issued a dividend of $0.5391 per share. This represents a $2.16 annualized dividend and a yield of 8.1%. The ex-dividend date is Thursday, April 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
